You are here

  • Home
  • Archive
  • Volume 64, Issue Suppl 1
  • PTU-105 Real world effectiveness, safety and cost per cure in hepatitis C patients treated with protease inibitor based therapy: results from the HCV research UK cohort

Citation Tools

Article menu
Download PDFPDF
Liver – Viral Hepatitis
PTU-105 Real world effectiveness, safety and cost per cure in hepatitis C patients treated with protease inibitor based therapy: results from the HCV research UK cohort

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Barclay S, Cooke G, Irving W on behalf of HCV Research UK, et al
PTU-105 Real world effectiveness, safety and cost per cure in hepatitis C patients treated with protease inibitor based therapy: results from the HCV research UK cohort
Gut 2015;64:A107-A108.